Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroma, Acoustic × Magnetic Resonance Spectroscopy × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 25 Neoplasm Metastasis 21 Lung Neoplasms 20 Carcinoma, Non-Small-Cell Lung 18 Multiple Myeloma 15 Carcinoma, Renal Cell 14 Melanoma 13 Glioblastoma 13 Urinary Bladder Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 12 Triple Negative Breast Neoplasms 11 Ovarian Neoplasms 11 Mouth Neoplasms 11 Carcinoma 11 Oropharyngeal Neoplasms 10 Laryngeal Neoplasms 10 Glioma 10 Colorectal Neoplasms 10 Breast Neoplasms 10 Lymphoma 9 Hypopharyngeal Neoplasms 9 Fallopian Tube Neoplasms 9 Carcinoma, Transitional Cell 9 Pancreatic Neoplasms 8 Endometrial Neoplasms 8 Brain Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 7 Leukemia, Myeloid, Acute 7 Burkitt Lymphoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

Sufentanil 1 ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡